Uses its Network Biology system to discover and develop cancer treatments.
Industry: Health Care
First Day Return: -13.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/08/2011 |
Offer Price | $7.00 |
Price Range $7.00 - $7.00 | |
Offer Shares (mm) | 14.3 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/28/2012 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 1993 |
Employees at IPO | 218 |
Website www.merrimackpharma.com |